We present a case of a late-preterm infant admitted for suspected cyanotic heart disease who was found to have a thrombosed ductus arteriosus. Maternal history was significant for heterozygosity for Factor V Leiden, treated with enoxaparin during her pregnancy, and congenital hearing loss. The neonate did not have a Factor V Leiden mutation detected, but was found to have a heterozygous mutation within the MFTHR gene. He was treated with anticoagulation, with improving hemodynamics measured by echocardiogram. This case presents a rare disease, which is potentially fatal if diagnosis is delayed.
Introduction
Arterial thrombosis is rare in the neonatal period, with greater than 90% of cases occurring with an arterial access device. 1 Most infants present with evidence of arterial insufficiency including limb ischemia, or if associated with umbilical artery catheterization, the thrombosis may mimic coarctation of the aorta. 1 Arterial thrombosis is only infrequently reported with a presentation suggestive of other congenital heart defects. We present a case of an infant who was suspected of having cyanotic heart disease, but was found to have a perinatal occlusive thrombosis of the ductus arteriosus. The timely diagnosis and treatment led to favorable outcome.
Case
A 36-week gestation male, weighing 2.765 kg, was born via elective repeat cesarean section to a 34-year-old G6P3 Caucasian female with familial congenital hearing loss and heterozygosity for factor V Leiden, for which she received enoxaparin during her pregnancy. The pregnancy was also complicated by gestational diabetes, which was controlled by diet. Maternal blood type was A þ and prenatal laboratory tests were normal. Apgar scores were 8 and 9 at 1 and 5 min, respectively. Physical examination was remarkable for cyanosis, a grade 1 systolic murmur over left sternal border and a loud second heart sound. Oxygen saturations on room air were in the 60s and increased into the 80s with blow-by oxygen. A chest radiograph showed slight prominence of the cardiac silhouette. Umbilical artery and vein catheters were placed and confirmed in proper position. Prostaglandin E1 was started because of suspected cyanotic congenital heart disease.
The neonate was transferred from the delivery hospital to a regional tertiary pediatric hospital for further evaluation. An echocardiogram demonstrated a 7-mm diameter by 10-mm length mass within the main pulmonary artery, occupying most of the main pulmonary artery lumen; moderately increased right ventricular wall and interventricular septal wall thickness, no evidence of ductus arteriosus flow and bidirectional shunting through a 4-mm patent foramen ovale. Computed tomography angiography of the chest with contrast ( Figure 1 ) demonstrated a low density structure in the ductus arteriosus, extending from the main pulmonary artery to the proximal descending aorta consistent with a large thrombus.
Systemic anticoagulation was initiated with heparin and changed to enoxaparin when the infant was stable. Thrombocytopenia was treated with platelet transfusions. Systemic thrombolytic therapy was considered, but not initiated because of increased risk of bleeding. Cardiovascular surgery was consulted for possible surgical thrombectomy. Follow-up echocardiogram after 7 days of anticoagulation showed some dissolution of the pulmonary artery portion of the thrombus, with good blood flow through the right pulmonary artery, but persistent mild obstruction of the left pulmonary artery. At this time, it was felt that no surgical intervention was required. Arterial oxygen saturations were maintained in the 90s, with supplemental oxygen by nasal cannula.
Hematological evaluation was performed to rule out a hypercoagulability disorder. Protein C and protein S levels were normal; anti-thrombin III level was borderline (39%), but normalized after initial supplementation. Genetic screenings for factor V Leiden and prothrombin gene mutations were negative, but he had a heterozygous mutation for the MTHFR gene (C677T mutation). He was discharged on day of life 14, with a plan for a 3-month course of enoxaparin.
Discussion
Perinatal and prenatal thrombosis of the ductus arteriosus, with obstruction of the distal pulmonary trunk, is an unusual and potentially lethal event. 2 In the four previous case reports describing pulmonary artery thrombosis, the initial presentation occurred from several days to 12 days of life. [3] [4] [5] [6] However, the infant in the current case report was cyanotic at birth, complicating the diagnosis. It is likely that the development of thrombus in this infant occurred prenatally. This case illustrates the importance of an echocardiogram and pulse oximetry in evaluating a cyanotic neonate. 3 When an echocardiogram is suspicious, but not diagnostic of a thrombus, further imaging including cardiac catheterization or computed tomography angiography can assist in the diagnosis, 5 as performed in our case. Management of arterial thrombosis in the neonatal period remains controversial because of the rare occurrence and lack of consensus in treatment options, with less emphasis on pulmonary artery thrombosis. 7 Treatment options include anticoagulation therapy with heparin or low-molecular weight heparins, thrombolytic therapy or surgery. The optimal treatment is determined by clinical factors, including the infant's condition, risk of bleeding, degree of organ damage and surgical expertise. 1 In all four of the previous case reports, systemic anticoagulation was attempted, but two of the neonates required surgical removal of the thrombosis after failed anticoagulation therapy. In our case, use of thrombolytic therapy was considered but not initiated because risk of hemorrhage outweighed the perceived benefit. Surgical intervention was also considered, but the thrombosis resolved with conservative treatment. Genetic testing for causes of hypercoagulability revealed heterozygosity for a MTHFR gene mutation, which alone would not account for the thrombosis. The infant will undergo further testing after completing the enoxaparin course.
The prognosis of our case is undetermined at this time, although the infant was clinically stable at discharge. He did continue to require supplemental oxygen, presumably because of altered fetal pulmonary blood flow, resulting in pulmonary vascular remodeling, which has previously been described in cases of altered fetal blood flow. 8 
Conclusion
This case represents a rare and potentially fatal prenatal ductus arteriosus thrombosis, resulting in hypoxia at birth. The findings from the echocardiogram, performed to rule out congenital heart disease, led to the diagnosis of perinatal thrombosis of the ductus arteriosus with extension in the main pulmonary artery, which was successfully treated conservatively with anticoagulation. Figure 1 Computed tomography angiography with contrast of the chest. Lowdensity mass (arrows) extending from the pulmonary vein to the descending aorta consistent with a thrombosed ductus arteriosus.
